Zobrazeno 1 - 10
of 446
pro vyhledávání: '"Bezman, N"'
Autor:
Aghaee M; Laboratory for Systems Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Ledzewicz U; Institute of Mathematics, Lodz University of Technology, Lodz, Poland; Dept. of Mathematics and Statistics, Southern Illinois University Edwardsville, Edwardsville, IL, USA., Robbins M; io904 LLC, Jacksonville Beach, FL, USA., Bezman N; Oncology Research and Development, Pfizer, La Jolla, California, USA., Jay Cho H; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Moore H; Laboratory for Systems Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: helen.moore@medicine.ufl.edu.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Aug 01; Vol. 187, pp. 106492. Date of Electronic Publication: 2023 Jun 09.
Autor:
D'Souza C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne. criselle.dsouza@petermac.org., Keam SP; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne., Yeang HXA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Neeson M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Richardson K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Hsu AK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Canfield R; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Bezman N; Oncology Discovery Research, Bristol-Myers Squibb, Redwood City, CA, USA. Current: Arsenal Bio, San Francisco, CA 94080., Robbins M; Translational Medicine, Bristol-Myers Squibb, Cambridge, MA, USA, (current: io904 LLC)., Quach H; Department of Hematology, St Vincent's Hospital, Melbourne, Australia; Faculty of Medicine, University of Melbourne., Ritchie DS; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia; Faculty of Medicine, University of Melbourne, Australia; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Harrison SJ; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne., Prince HM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne. paul.neeson@petermac.org.
Publikováno v:
Haematologica [Haematologica] 2021 Sep 01; Vol. 106 (9), pp. 2522-2526. Date of Electronic Publication: 2021 Sep 01.
Autor:
Huang RY; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States., Wang Y; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States., Jhatakia AD; Discovery Biology, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Deng AX; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Bee C; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Deshpande S; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Rangan VS; Discovery Biotherapeutics, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Bezman N; Discovery Biology, Research and Early Development, Bristol Myers Squibb Company, Redwood City, California United States., Gudmundsson O; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States., Chen G; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey United States.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2021 Jul 07; Vol. 32 (7), pp. 1567-1574. Date of Electronic Publication: 2021 Jan 08.
Autor:
Meermeier EW; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Welsh SJ; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Sharik ME; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Du MT; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Garbitt VM; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Riggs DL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Shi CX; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Stein CK; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Bergsagel M; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Chau B; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California., Wheeler ML; Tumor Microenvironment Thematic Research Center, Bristol Myers Squibb, Redwood City, California., Bezman N; Tumor Microenvironment Thematic Research Center, Bristol Myers Squibb, Redwood City, California., Wang F; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California., Strop P; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California., Bergsagel PL; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Chesi M; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona. chesi.marta@mayo.edu.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2021 Jul; Vol. 2 (4), pp. 354-369.
Autor:
Huang RY; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08540, United States., Wang F; Protein Engineering, Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States., Wheeler M; Discovery Biology, Research and Early Development, Bristol Myers Squibb, Redwood City, California 94063, United States., Wang Y; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08540, United States., Langish R; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08540, United States., Chau B; Protein Engineering, Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States., Dong J; Protein Engineering, Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States., Morishige W; Protein Engineering, Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States., Bezman N; Discovery Biology, Research and Early Development, Bristol Myers Squibb, Redwood City, California 94063, United States., Strop P; Protein Engineering, Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States., Rajpal A; Protein Engineering, Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States., Gudmundsson O; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08540, United States., Chen G; Pharmaceutical Candidate Optimization, Nonclinical Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08540, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2020 Aug 04; Vol. 92 (15), pp. 10709-10716. Date of Electronic Publication: 2020 Jul 22.
Autor:
Wong P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Leong JW; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Sohn H; Divison of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA., Chang L; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Keppel CR; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Neal CC; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Cubitt CC; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Yao T; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Keppel MP; Divison of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA., Tran J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Burdi A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Hwang K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Fogel LA; Divison of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA., Schappe T; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Marsala L; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Berrien-Elliott MM; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Wagner JA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Schneider SE; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Sullivan RP; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Pingel JT; Divison of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA., Cooper MA; Divison of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA., French AR; Divison of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA., Fehniger TA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Publikováno v:
European journal of immunology [Eur J Immunol] 2024 Sep 09, pp. e2451173. Date of Electronic Publication: 2024 Sep 09.
Autor:
Benoist, C, Lanier, L, Merad, M, Mathis, D, Ericson, J, Painter, M, Davis, S, Laplace, C, Hyatt, G, Paik, H, Rothamel, K, Cruse, R, Doran, G, Heng, T, Asinovski, N, Ortiz-Lopes, A, Ergun, A, Gray, D, Wakamatsu, E, Hill, J, Mingueneau, M, Cipolletta, D, Yoshida, H, Cohen, N, Kim, E, Brennan, P, Lynch, L, Brenner, M, Costello, J, Collins, JJ, Blair, D, Dustin, M, Knell, J, Yang, E, Best, A, Shaw, L, Doedens, A, Goldrath, A, Shinton, S, Zhou, Y, Hardy, R, Jojic, V, Mostafavi, S, Koller, D, Jianu, R, Laidlaw, D, Bezman, N, Sun, J, Zhu, Y, Hendricks, D, Kamimura, Y, Min-Oo, G, Morvan, M, Nabekura, T, Lam, V, Kim, C, Greter, M, Helft, J, Chow, A, Bogunovic, M, Mortha, A, Price, J, Hashimoto, D, Miller, J, Sathe, P, Chudnovskiy, A, Lavin, Y, Idoyaga, J, Gautier, E, Jakubzick, C, D'Angelo, J, Randolph, G, Shay, T, Regev, A, Gazit, R, Rossi, D, Kreslawsky, T, von Bohmer, H, Bellemare-Pelletier, A, Elpek, K, Spelv, L, Fletcher, A, Malhotra, D, Cremasco, V, Turley, S, Kim, F, Nageswara Rao, T, Wagers, A
Publikováno v:
Nature Reviews Immunology, vol 14, iss 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::08ca7b84d3111718caea8aa96f88d1e6
https://escholarship.org/uc/item/3t49w4sj
https://escholarship.org/uc/item/3t49w4sj
Autor:
Benoist, C, Lanier, L, Merad, M, Mathis, D, Ericson, J, Painter, M, Davis, S, Laplace, C, Hyatt, G, Paik, H, Rothamel, K, Cruse, R, Doran, G, Heng, T, Asinovski, N, Ortiz-Lopes, A, Ergun, A, Gray, D, Wakamatsu, E, Hill, J, Mingueneau, M, Cipolletta, D, Yoshida, H, Cohen, N, Kim, E, Brennan, P, Lynch, L, Brenner, M, Costello, J, Collins, JJ, Blair, D, Dustin, M, Knell, J, Yang, E, Best, A, Shaw, L, Doedens, A, Goldrath, A, Shinton, S, Zhou, Y, Hardy, R, Jojic, V, Mostafavi, S, Koller, D, Jianu, R, Laidlaw, D, Bezman, N, Sun, J, Zhu, Y, Hendricks, D, Kamimura, Y, Min-Oo, G, Morvan, M, Nabekura, T, Lam, V, Kim, C, Greter, M, Helft, J, Chow, A, Bogunovic, M, Mortha, A, Price, J, Hashimoto, D, Miller, J, Sathe, P, Chudnovskiy, A, Lavin, Y, Idoyaga, J, Gautier, E, Jakubzick, C, D'Angelo, J, Randolph, G, Shay, T, Regev, A, Gazit, R, Rossi, D, Kreslawsky, T, von Bohmer, H, Bellemare-Pelletier, A, Elpek, K, Spelv, L, Fletcher, A, Malhotra, D, Cremasco, V, Turley, S, Kim, F, Nageswara Rao, T, Wagers, A
Publikováno v:
Benoist, C; Lanier, L; Merad, M; Mathis, D; Ericson, J; Painter, M; et al.(2012). Consortium biology in immunology: The perspective from the Immunological Genome Project. Nature Reviews Immunology, 12(10), 734-740. doi: 10.1038/nri3300. UCSF: Retrieved from: http://www.escholarship.org/uc/item/57j375n0
Although the field has a long collaborative tradition, immunology has made less use than genetics of 'consortium biology', wherein groups of investigators together tackle large integrated questions or problems. However, immunology is naturally suited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::ec24a3b6c21a1a653ac5c47fb7cb09a1
http://www.escholarship.org/uc/item/57j375n0
http://www.escholarship.org/uc/item/57j375n0
Autor:
Gallaher J; H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA. Electronic address: jill.gallaher@moffitt.org., Larripa K; Department of Mathematics, Humboldt State University, Arcata, CA 95521, USA. Electronic address: kamila.larripa@humboldt.edu., Renardy M; Department of Mathematics, The Ohio State University, Columbus, OH 43210, USA; Current affiliation: Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: renardy@umich.edu., Shtylla B; Mathematics Department, Pomona College, Claremont, CA 91711, USA. Electronic address: shtyllab@pomona.edu., Tania N; Department of Mathematics and Statistics, Smith College, Northampton, MA 01063,USA. Electronic address: ntania@smith.edu., White D; Department of Mathematics, Clarkson University, Potsdam, NY 13699, USA. Electronic address: dtwhite@clarkson.edu., Wood K; Department of Mathematics, University of California at Irvine, Irvine, CA 92697, USA; Current affiliation: The Aerospace Corporation, El Segundo, CA 90245, USA. Electronic address: kewood@uci.edu., Zhu L; Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, Princeton, NJ 08543, USA. Electronic address: li.zhu@bms.com., Passey C; Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, Princeton, NJ 08543, USA; Current affiliation: Genmab, Monmouth Junction, NJ 08852, USA., Robbins M; Hematology Medical Strategy, Bristol-Myers Squibb, Lawrence Township, NJ 08648, USA. Electronic address: michael.robbins@bms.com., Bezman N; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA 94063, USA. Electronic address: natalie.bezman@bms.com., Shelat S; Oncology Clinical Development, Bristol-Myers Squibb, Lawrence Township, NJ 08648, USA. Electronic address: suresh.shelat@bms.com., Jay Cho H; Tisch Cancer Institute, Mt. Sinai School of Medicine, New York, NY 10029, USA. Electronic address: hearn.jay.cho@mssm.edu., Moore H; Bristol-Myers Squibb, Princeton, NJ 08543, USA; Current affiliation: AstraZeneca, Waltham, MA 02451, USA. Electronic address: dr.helen.moore@gmail.com.
Publikováno v:
Journal of theoretical biology [J Theor Biol] 2018 Dec 07; Vol. 458, pp. 31-46. Date of Electronic Publication: 2018 Aug 30.
Autor:
Li, Yu1 (AUTHOR), Zhang, Cangang2 (AUTHOR), Jiang, Aimin3 (AUTHOR), Lin, Anqi1 (AUTHOR), Liu, Zaoqu4,5 (AUTHOR), Cheng, Xiangshu6 (AUTHOR), Wang, Wanting7 (AUTHOR), Cheng, Quan8 (AUTHOR) chengquan@csu.edu.cn, Zhang, Jian1 (AUTHOR) zhangjian@i.smu.edu.cn, Wei, Ting1 (AUTHOR) weitingyouyou@qq.com, Luo, Peng1 (AUTHOR) luopeng@smu.edu.cn
Publikováno v:
Journal of Translational Medicine. 3/20/2024, Vol. 22 Issue 1, p1-21. 21p.